John Oliver ropes in Bryan Cranston, Michael Keaton to help punish Purdue Pharma's Richard Sackler for hiding

John Oliver on Purdue Pharma

The opioid epidemic "is very much ongoing" but "we've learned a lot more about many of the companies involved" since Last Week Tonight last covered the issue in October 2016, John Oliver said Sunday night. The first chapter of the opioid crisis turns out to be "a story of how major companies acted wildly irresponsibly, skirted any meaningful consequences, and for the most part, avoided public scrutiny," he said. "For companies involved in the opioid crisis, fines just became the cost of doing business, and throughout this crisis it has been difficult to find any real accountability for the people involved."

Oliver briefly highlighted the drug distributors, but his main example of lack of accountability was "Purdue Pharma, the manufacturer behind OxyContin," he said. Purdue is owned by members of the Sackler family, collectively worth about $13 billion.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.